SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-092360
Filing Date
2022-04-01
Accepted
2022-03-31 20:57:58
Documents
14
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d345612d8k.htm   iXBRL 8-K 31585
2 EX-5.1 d345612dex51.htm EX-5.1 6345
3 EX-10.1 d345612dex101.htm EX-10.1 207840
  Complete submission text file 0001193125-22-092360.txt   433785

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fbrx-20220331.xsd EX-101.SCH 2865
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbrx-20220331_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbrx-20220331_pre.xml EX-101.PRE 11713
8 EXTRACTED XBRL INSTANCE DOCUMENT d345612d8k_htm.xml XML 3471
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38052 | Film No.: 22795377
SIC: 2834 Pharmaceutical Preparations